This GLP-1 medications list covers every FDA-approved GLP-1 receptor agonist and dual or triple incretin agonist in use in 2026, organised by active ingredient, brand name, drug type, approved use, and dosing form
Every medication that produces weight loss also faces the challenge of weight regain
Semaglutide has been demonstrated to suppress PI3K/AKT/mTORC1 signaling in obese mice [23], suggesting an antisteatotic effect independent of weight loss
Whether you are dealing with persistent nausea, trying to navigate a medication shortage, or simply looking for a way to transition into a maintenance phase, the question often arises: can I take Wegovy every 10 days instead of 7
PRIORITY LIST Medicines and health innovations for which voluntary licensing and/or technology transfer through MPP would lead to expanded access, significant health benefits, and substantial public health impact compared to standards of care